Next week's earnings calendar is packed with major names. For the week of November 3 - 7, 2025, five of the largest companies (by market cap) scheduled to report include Advanced Micro Devices, Qualcomm, Pfizer, Novo Nordisk, AstraZeneca. Below we highlight each company's most recent quarterly performance and when they report (BMO = before market open; AMC = after market close).

Top 5 Earnings to Watch

Pfizer (PFE) — Tuesday, Nov 4, 2025 (BMO)

Pfizer reports Q3 2025 before the open; the webcast is at 10:00 a.m. ET. Last quarter (Q2 2025): adjusted EPS $0.78; revenue $14.65B. YTD: -7.99%. Watch: Vyndaqel and Eliquis growth, COVID franchise seasonality, cost-saving program flow-through to 2025 EPS (raised to $2.90-$3.10), and color on late-stage pipeline (oncology/vaccines).

Advanced Micro Devices (AMD) — Tuesday, Nov 4, 2025 (AMC)

AMD will post fiscal Q3 2025 after the bell (5:00 p.m. ET). Last quarter (Q2 FY2025): GAAP EPS $0.54 (non-GAAP $0.48); revenue $7.68B. YTD: +115% as of Oct 31. Watch: MI350 AI accelerator ramp and EPYC server momentum (management flagged a “significant” H2 ramp), progress on the OpenAI 6-gigawatt GPU partnership, client PC recovery, and gross-margin trajectory after the Q2 inventory charge; look for Q4 guideposts on DC GPU supply.

Novo Nordisk (NVO) — Wednesday, Nov 5, 2025 (BMO)

Novo Nordisk will post Q3 2025 before the Copenhagen market opens. Last quarter (Q2 2025): diluted EPS $0.97; sales $12.13B. YTD: -43.98%. Watch: GLP-1 trends (Wegovy/Ozempic volumes), updates on compounded-semaglutide headwinds and any revisions to the reduced FY2025 outlook, plus capacity/pricing commentary.

QUALCOMM (QCOM) — Wednesday, Nov 5, 2025 (AMC)

Qualcomm reports Q4 FY2025 after the close. Last quarter (Q3 FY2025): non-GAAP EPS $2.77; revenue $10.37B. YTD: +18.26%. Watch: on-device AI/AI PC adoption (Snapdragon X), Android flagship cycle, diversification (auto/IoT) vs. modem sunset with Apple, and Q4/FY26 outlook.

AstraZeneca (AZN) — Thursday, Nov 6, 2025 (BMO)

AstraZeneca posts 9M & Q3 2025 at 07:00 GMT. Last quarter (Q2 2025): EPS $1.09; revenue $14.46B. YTD: +23%. Watch: oncology growth (Tagrisso/Enhertu/Lynparza), U.S. expansion investments and mix, China demand/pricing backdrop, and whether FY2025 guidance (high-single-digit rev growth, low-double-digit core EPS growth) is reiterated.

Digging Deeper with Earnings Call Transcript Data

For beyond-the-headlines context, earnings call transcripts are invaluable. Financial Modeling Prep's API returns full calls (management remarks + Q&A) in JSON. For example, Apple's Q2 2025 transcript:

https://financialmodelingprep.com/api/v3/earning_call_transcript/AAPL?year=2025&quarter=2&apikey=YOUR_API_KEY

Fields include ticker, quarter, year, date, and full text—handy for quick sentiment and strategy checks.

Also see: Check how top companies reported in the previous week (Oct 27 - Oct 31) for added context as you prep for this slate.